ReviewFrontiers in oncology2023

Targeting sterol-O-acyltransferase 1 to disrupt cholesterol metabolism for cancer therapy.

Teng Tu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.